FindTrial
Sign In

A study on prescription pattern and its effect on lipid profile among ischemic heart disease

A study on prescription pattern and lipid profile among ischemic heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047269
Enrollment
298
Registered
2022-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients greater than 18 years of age and diagnosed with ischemic heart disease, who were prescribed with statin therapy and completed 3 months of statin therapy.

Exclusion criteria

Exclusion criteria: Participants with elevated liver enzymes and not fit for statin therapy, Pregnant women, Critically ill patients, Psychiatry patients and Participants not willing to participate in study

Design outcomes

Primary

MeasureTime frame
To assess the lipid profile of ischemic heart disease participants who are on statin therapyTimepoint: single point—

Secondary

MeasureTime frame
To analyze the prescription patterns of ischemic heart disease participantsTimepoint: single point—

Countries

India

Contacts

Public ContactDr Basavaraj Utagi

NGSM Institute of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026